SCHEMBL9058014

SCHEMBL9058014

Cn1cc(-c2cccc(CNCc3ccccc3)c2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSV O60911 1/20 0.49
▸ CTSL P07711 1/20 0.49
▸ CTSB P07858 1/20 0.49
▸ CTSS P25774 1/20 0.49
▸ IRAK1 P51617 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ CLK1 P49759 1/20 0.46
▸ AURKB Q96GD4 2/20 0.46
▸ MPO P05164 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ WNT1 P04628 2/20 0.46
▸ GSK3B P49841 2/20 0.46
▸ DYRK1A Q13627 2/20 0.46
▸ EPHX2 P34913 1/20 0.46
▸ KDR P35968 1/20 0.45
▸ EPHB4 P54760 1/20 0.45
▸ GPR142 Q7Z601 1/20 0.45
▸ AXL P30530 2/20 0.44
▸ ROCK2 O75116 1/20 0.44
▸ PFKFB3 Q16875 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31182034 0.80 PFKFB3 (0.48) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL17547081 0.80 PFKFB3 (0.48) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL16597444 0.79 TEK (0.47) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL18492830 0.79 LOXL2 (0.51) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL16675749 0.79 PRKCI (0.51) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL22000113 0.78 BCHE (0.55) —
SCHEMBL8811228 0.78 IRAK1 (0.51) IRAK1IRAK4MAPK1AXLNMT1
SCHEMBL3340159 0.77 TAAR1 (0.46) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL30570078 0.77 MPO (0.45) CTSVCTSLCTSBCTSSIRAK1
SCHEMBL30570082 0.77 MPO (0.45) CTSVCTSLCTSBCTSSIRAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 — — WO disclosed
Send feedback